Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
This study has been withdrawn prior to enrollment.
(the study failed to enroll any patient and sponsor wished to stop.)
University of North Carolina, Chapel Hill
Information provided by (Responsible Party):
Patrick Nachman, MD, University of North Carolina, Chapel Hill
First received: December 13, 2010
Last updated: March 29, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||December 2012|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|